UnitedHealth Group (UNH) Stock Surges to 52-Week Peak Following Impressive Q1 Performance

Key Takeaways

Table of Contents

UNH reached a 52-week peak of $404.14 mid-week, climbing approximately 30% in the last 30 days
First quarter revenues totaled $111.7 billion, representing a 2% annual increase, while adjusted EPS exceeded forecasts at $7.23
Operating margins at UnitedHealthcare expanded from 6.2% to 6.6% during the first quarter
The company’s Medical Care Ratio declined to 83.9% in Q1, a significant improvement from the previous quarter’s 88.9%
Strategic reduction of 1.3 million Medicare Advantage members in 2026 aims to preserve profitability

UnitedHealth Group (UNH) reached a 52-week peak of $404.14 during Wednesday’s trading session, concluding an impressive rally that pushed shares up approximately 30% during the previous month.

UnitedHealth Group Incorporated, UNH

For the current year, UNH has advanced roughly 21%. Looking at the trailing twelve-month period, the stock has delivered gains of about 29%.

This upward momentum represents a dramatic reversal from earlier weakness. Between January and late March, shares tumbled from $336 down to $259 — representing approximately a 23% decline.

The turnaround gained momentum following UnitedHealth’s first quarter earnings report in late April, which surpassed Wall Street estimates and included an upward revision to full-year guidance.

First quarter revenues reached $111.7 billion, marking a 2% year-over-year expansion. Adjusted earnings per share landed at $7.23, exceeding analyst projections. Reported EPS registered at $6.90.

UnitedHealthcare’s operating margins expanded from 6.2% to 6.6%, representing a modest yet significant enhancement for an organization navigating a transitional phase.

Medicare Advantage Continues to Present Challenges

Medicare Advantage has emerged as one of the more prominent headwinds for UNH. Federal reimbursement rates have failed to match the acceleration in program expenses, creating margin compression in recent years.

To address this dynamic, UnitedHealth strategically reduced its Medicare Advantage enrollment by 1.3 million participants for 2026. While challenging, leadership characterized this decision as essential for maintaining long-term financial health.

The financial results are reflecting this strategic shift. UnitedHealth’s Medical Care Ratio — representing the portion of premium revenue allocated to claims payments — dropped to 83.9% in Q1, compared to 88.9% in the fourth quarter of 2025.

This substantial quarter-over-quarter improvement indicates the enrollment reductions are already positively impacting the company’s cost profile.

Early 2025 Presented a Contrasting Scenario

The start of 2025 proved turbulent. UnitedHealth experienced significant selling pressure in early January following disappointing fourth quarter 2024 results and a Centers for Medicare & Medicaid Services proposal for Medicare Advantage rate adjustments that fell short of industry expectations.

The organization has additionally navigated executive transitions and an active antitrust review. While these concerns persist, market participants currently appear focused on operational performance rather than these ongoing issues.

At its current valuation near $400, UNH offers a dividend yield of approximately 2.3%, with a market capitalization hovering around $360 billion.

The stock’s 52-week trading range extends from $234.60 to $404.15 — with Wednesday’s high matching the upper boundary of that range.

Wednesday’s volume registered approximately 4.8 million shares, trailing the average daily volume of 8.5 million, indicating the advance occurred without exceptional trading activity.

UNH closed Wednesday’s session at $400.38 according to the most recent available pricing data.

✨ Limited Time Offer